Clinical Trial

Alpha Radiation Emitters Device for the Treatment of Advanced Pancreatic Cancer

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
A unique approach for cancer treatment employing intratumoral diffusing alpha radiation emitter device for advanced pancreatic cancer.
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2019-06-27; most recent amendment 2025-12-01.
Status change: Recruiting → Active, Not Recruiting 2025-12-01
Status change: Not Yet Recruiting → Recruiting 2021-03-15
Trial Details
NCT Number NCT04002479
Lead Sponsor Alpha Tau Medical LTD.
Conditions Pancreatic Cancer, Unresectable Pancreatic Cancer, Metastatic Pancreatic Cancer, Pancreatic Adenocarcinoma
Enrollment 37 participants
Start Date 2020-10-20
Primary Completion 2026-10 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-12-02